Study of Single Agent CJM112, and PDR001 in Combination With LCL161 or CJM112 in Patients With Multiple Myeloma
Clinical trial NCT03111992 · COMPLETED
Trial details
- NCT number
- NCT03111992
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-12-18
- Primary completion
- 2020-03-02
- Enrollment
- 26
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.